Terms: = Lymphoma AND ARID2, ENSG00000189079, 196528, Q68CP9, p200, KIAA1557, FLJ30619, DKFZp779P0222, DKFZp686G052, BAF200
5 results:
1. Concomitant novel ALK-SSH2, EML4-ALK and arid2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively.
Tao H; Liu Z; Mu J; Gai F; Huang Z; Shi L
Diagn Pathol; 2022 Feb; 17(1):27. PubMed ID: 35144623
[TBL] [Abstract] [Full Text] [Related]
2. Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.
Almeida ARM; Neto JL; Cachucho A; Euzébio M; Meng X; Kim R; Fernandes MB; Raposo B; Oliveira ML; Ribeiro D; Fragoso R; Zenatti PP; Soares T; de Matos MR; Corrêa JR; Duque M; Roberts KG; Gu Z; Qu C; Pereira C; Pyne S; Pyne NJ; Barreto VM; Bernard-Pierrot I; Clappier E; Mullighan CG; Grosso AR; Yunes JA; Barata JT
Nat Commun; 2021 Dec; 12(1):7268. PubMed ID: 34907175
[TBL] [Abstract] [Full Text] [Related]
3. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
[TBL] [Abstract] [Full Text] [Related]
4. Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders.
Margolskee E; Jobanputra V; Jain P; Chen J; Ganapathi K; Nahum O; Levy B; Morscio J; Murty V; Tousseyn T; Alobeid B; Mansukhani M; Bhagat G
Oncotarget; 2016 Jun; 7(25):37636-37648. PubMed ID: 27203213
[TBL] [Abstract] [Full Text] [Related]
5. Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins.
Veeranki S; Choubey D
Immunol Lett; 2010 Sep; 133(1):1-5. PubMed ID: 20599558
[TBL] [Abstract] [Full Text] [Related]
